DCX and CRABP2 are candidate genes for differential diagnosis between pre‐chemotherapy embryonic and alveolar rhabdomyosarcoma in pediatric patients

• Main Authors: Nian Sun (Author), Yeran Yang (Author), Shengcai Wang (Author), Jie Zhang (Author), Jingang Gui (Author), Jun Tai (Author), Lejian He (Author), Jiatong Xu (Author), Yanzhen Li (Author), Xuexi Zhang (Author), Qiaoyin Liu (Author), Zhiyong Liu (Author), Yongli Guo (Author), Xin Ni (Author)
• Format: Book
• Published: Wiley, 2021-06-01T00:00:00Z.
• Subjects: article
• Online Access: Connect to this object online.

ABSTRACT Importance Rhabdomyosarcoma (RMS) is the most common soft tissue sarcoma in children. More than 90% of cases are classified as embryonic RMS (ERMS) or alveolar RMS (ARMS). ERMS has a worse prognosis than ARMS. Early differential diagnosis is of paramount importance for optimization of treat...